Wayne Rycroft

2.0k total citations
21 papers, 1.5k citations indexed

About

Wayne Rycroft is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Surgery. According to data from OpenAlex, Wayne Rycroft has authored 21 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cellular and Molecular Neuroscience, 12 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in Wayne Rycroft's work include Neuropeptides and Animal Physiology (14 papers), Receptor Mechanisms and Signaling (9 papers) and Pharmacological Receptor Mechanisms and Effects (5 papers). Wayne Rycroft is often cited by papers focused on Neuropeptides and Animal Physiology (14 papers), Receptor Mechanisms and Signaling (9 papers) and Pharmacological Receptor Mechanisms and Effects (5 papers). Wayne Rycroft collaborates with scholars based in United States and United Kingdom. Wayne Rycroft's co-authors include F.D. Tattersall, Richard Hargreaves, S.D. Iversen, Colin T. Dourish, R.G. Hill, Margaret A. Cascieri, Gerard R. Dawson, D. Euan MacIntyre, Angus M. MacLeod and Christopher J. Swain and has published in prestigious journals such as Science, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Wayne Rycroft

21 papers receiving 1.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Wayne Rycroft 779 605 404 273 211 21 1.5k
F.D. Tattersall 802 1.0× 774 1.3× 725 1.8× 415 1.5× 204 1.0× 30 2.0k
Michael B. Tyers 977 1.3× 716 1.2× 164 0.4× 375 1.4× 134 0.6× 24 1.5k
Pao‐Luh Tao 1.4k 1.8× 896 1.5× 179 0.4× 842 3.1× 134 0.6× 105 2.3k
John C. Doxey 905 1.2× 1.1k 1.8× 157 0.4× 501 1.8× 252 1.2× 35 1.9k
Michel Laubie 677 0.9× 709 1.2× 174 0.4× 524 1.9× 159 0.8× 91 1.8k
P. A. van Zwieten 820 1.1× 1.0k 1.7× 129 0.3× 426 1.6× 89 0.4× 115 2.0k
Nirmala Suman‐Chauhan 909 1.2× 816 1.3× 161 0.4× 420 1.5× 208 1.0× 39 1.7k
M. Bansinath 544 0.7× 440 0.7× 258 0.6× 446 1.6× 36 0.2× 72 1.3k
Alexander T. McKnight 1.5k 2.0× 1.2k 2.0× 163 0.4× 672 2.5× 71 0.3× 33 2.0k
L. Singh 899 1.2× 653 1.1× 124 0.3× 520 1.9× 49 0.2× 34 1.4k

Countries citing papers authored by Wayne Rycroft

Since Specialization
Citations

This map shows the geographic impact of Wayne Rycroft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wayne Rycroft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wayne Rycroft more than expected).

Fields of papers citing papers by Wayne Rycroft

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wayne Rycroft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wayne Rycroft. The network helps show where Wayne Rycroft may publish in the future.

Co-authorship network of co-authors of Wayne Rycroft

This figure shows the co-authorship network connecting the top 25 collaborators of Wayne Rycroft. A scholar is included among the top collaborators of Wayne Rycroft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wayne Rycroft. Wayne Rycroft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tessari, Michela, et al.. (2014). Physical dependence liability of retigabine in rats. Drug and Alcohol Dependence. 146. e2–e2. 1 indexed citations
2.
Dawson, Gerard R., Karen Maubach, Neil Collinson, et al.. (2006). An Inverse Agonist Selective for α5 Subunit-Containing GABAA Receptors Enhances Cognition. Journal of Pharmacology and Experimental Therapeutics. 316(3). 1335–1345. 207 indexed citations
3.
Hollingworth, Gregory J., Emma Carlson, José L. Castro, et al.. (2005). Novel lactam NK1 antagonists with anti-emetic activity. Bioorganic & Medicinal Chemistry Letters. 16(5). 1197–1201. 1 indexed citations
4.
Chambers, Mark S., John Atack, Robert W. Carling, et al.. (2004). An Orally Bioavailable, Functionally Selective Inverse Agonist at the Benzodiazepine Site of GABAA α5 Receptors with Cognition Enhancing Properties. Journal of Medicinal Chemistry. 47(24). 5829–5832. 90 indexed citations
5.
Huskey, Su-Er W., Brian J. Dean, Ray Bakhtiar, et al.. (2003). BRAIN PENETRATION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN FERRETS. Drug Metabolism and Disposition. 31(6). 785–791. 42 indexed citations
6.
Carlson, Emma, José L. Castro, Gary G. Chicchi, et al.. (2002). 4,4-Disubstituted cyclohexylamine NK1 receptor antagonists II. Bioorganic & Medicinal Chemistry Letters. 12(13). 1759–1762. 16 indexed citations
7.
Elliott, Jason, José L. Castro, Gary G. Chicchi, et al.. (2002). 4,4-Disubstituted cyclohexylamine NK1 receptor antagonists I. Bioorganic & Medicinal Chemistry Letters. 12(13). 1755–1758. 8 indexed citations
8.
Chicchi, Gary G., Jason Elliott, Gregory J. Hollingworth, et al.. (2001). 2-Aryl indole NK1 receptor antagonists: optimisation of the 2-Aryl ring and the indole nitrogen substituent. Bioorganic & Medicinal Chemistry Letters. 11(9). 1237–1240. 50 indexed citations
9.
Harrison, Timothy, Andrew P. Owens, Brian J. Williams, et al.. (2001). An Orally Active, Water-Soluble Neurokinin-1 Receptor Antagonist Suitable for Both Intravenous and Oral Clinical Administration. Journal of Medicinal Chemistry. 44(24). 4296–4299. 42 indexed citations
10.
Tattersall, F.D., Wayne Rycroft, M. Cumberbatch, et al.. (2000). The novel NK1 receptor antagonist MK–0869 (L–754,030) and its water soluble phosphoryl prodrug, L–758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets. Neuropharmacology. 39(4). 652–663. 120 indexed citations
11.
12.
Rupniak, N.M.J., F.D. Tattersall, Angela Williams, et al.. (1997). In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonists. European Journal of Pharmacology. 326(2-3). 201–209. 88 indexed citations
13.
Tattersall, F.D., Wayne Rycroft, B. Francis, et al.. (1996). Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets. Neuropharmacology. 35(8). 1121–1129. 189 indexed citations
14.
Ladduwahetty, T., Margaret A. Cascieri, Mark S. Chambers, et al.. (1996). N-Heteroaryl-2-phenyl-3-(benzyloxy)piperidines:  A Novel Class of Potent Orally Active Human NK1 Antagonists. Journal of Medicinal Chemistry. 39(15). 2907–2914. 56 indexed citations
15.
16.
Jackson, Anne, Graham Bentley, Wayne Rycroft, et al.. (1994). An investigation into the discriminative stimulus and reinforcing properties of the CCKB-receptor antagonist, L-365,260 in rats. Neuropeptides. 26(5). 343–353. 7 indexed citations
17.
Tattersall, F.D., Wayne Rycroft, R.G. Hill, & Richard Hargreaves. (1994). Enantioselective inhibition of ampomorphine-induced emesis in the ferret by the neurokinin1 receptor antagonist CP-99,994. Neuropharmacology. 33(2). 259–260. 75 indexed citations
18.
Tattersall, F.D., Wayne Rycroft, Richard Hargreaves, & R.G. Hill. (1993). The tachykinin NK1 receptor antagonist CP-99,994 attenuates cisplatin induced emesis in the ferret. European Journal of Pharmacology. 250(1). R5–R6. 88 indexed citations
19.
Boyce, S., N.M.J. Rupniak, L. Young, et al.. (1992). Antinociceptive effects of racemic RP67580, but not racemic CP96345, on acetic acid-induced writhing and formalin paw in mice. Neuropeptides. 22(1). 10–10. 5 indexed citations
20.
Dawson, Gerard R., et al.. (1991). The behavioral effects of heptyl physostigmine, a new cholinesterase inhibitor, in tests of long-term and working memory in rodents. Pharmacology Biochemistry and Behavior. 39(4). 865–871. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F.D. Tattersall Breakdown of academic impact, for papers by Michael B. Tyers Breakdown of academic impact, for papers by Pao‐Luh Tao Breakdown of academic impact, for papers by John C. Doxey Breakdown of academic impact, for papers by Michel Laubie Breakdown of academic impact, for papers by P. A. van Zwieten Breakdown of academic impact, for papers by Nirmala Suman‐Chauhan Breakdown of academic impact, for papers by M. Bansinath Breakdown of academic impact, for papers by Alexander T. McKnight Breakdown of academic impact, for papers by L. Singh
Rankless by CCL
2026